Loading...
DOCUMENTS
21
NOTICES
32
MOTS CLES
Eligibility
Endoscopic treatment
Ustekinumab
Small molecules
Disability
MARKER
Screening
Colorectal cancer Colibactin and lipids
Acceptability
Survival
T1118 translocation
Clinical trial
Algorithm
Patients experience
Ulcerative colitis
Cell adhesion
Cancer
MORTALITY
Heart disease risk factors
PCR
Upper gastrointestinal tract
IBD
DNA METHYLATION
Gene methylation
Vedolizumab
Immune cells
Immunosuppressant
Tuberculosis
Contraindication
Crohn's disease
Therapeutics
Microbiota
Gènes
18 FDG-PET/CT
Over 80s
Colon cancer
Inclusion
DNA methylation
MALT
Microbiote
Inhibitor
Colorectal cancer
Original Article Clinical
Colectomy
IL12
Venous thromboembolism
Résistance
Rituximab
Colon
Biologics
Gene expression
Bactéries
Primary sclerosing cholangitis
Safety
Rituximab plus chlorambucil
Disease Progression
Thérapie ciblée
Tailored therapy
Surgery
Parvimonas micra
RISK
Alkylating agents
Inflammatory bowel diseases
Neoadjuvant chemotherapy
Resistance
Colonic epithelial primary cells
Anti-TNF agents
Effectiveness
IL23
Maintenance therapy
Dysbiose
Dysbiosis
Cost effectiveness
Anti-TNF
Biomarker
Eradication
Consensus
Bacteria
Disease progression
COLON-CANCER
Clinical guidelines
Inflammatory bowel disease
Inflammatory Bowel Diseases
Méthylation
HIV
Monitoring
Crohn’s disease
Methylation
Kidney diseases
Genes
Drug
Epigenetics
CARCINOGENESIS
Epigénétiques
Fecal microbiota
Helicobacter pylori
Patient-reported outcome
Intestinal crypts
Stricture
MICROBIOTA
Early detection of Colon Cancer using Molecular Markers and Microbiota , EA 7375 | |
---|---|
Institutions |
UPEC |
Adresse |
Université Paris-Est Créteil Groupe Hospitalier Henri Mondor Service de Gastroentérologie 51 Av Maréchal de Lattre de Tassigny 94010 Créteil cedex |
Courriel |
|
Site Internet |
|
Rattachement(s) |
|
Direction |
Aurélien AMIOT |
Adjoint |
Iradj SOBHANI |
Axe(s) de recherche
|
Le laboratoire axe ses recherches sur le rôle du microbiome intestinal ainsi que des changements épigénétiques dans l'intestin afin :
|
Derniers dépôts
-
Lucas Guillo, Mathieu Uzzan, Laurent Beaugerie, Jean-Marc Gornet, Aurélien Amiot, et al.. Impact of HIV Infection on the Course of Inflammatory Bowel Disease and Drug Safety Profile: A Multicenter GETAID Study. Clinical Gastroenterology and Hepatology, 2022, 20 (4), pp.787-797.e2. ⟨10.1016/j.cgh.2020.12.023⟩. ⟨hal-04168380⟩
-
Iradj Sobhani, Emma Bergsten, Cecile Charpy, Mathias Chamaillard, Denis Mestivier. Virulent Bacteria as Inflammatory and Immune Co-Factor in Colon Carcinogenesis: Evidence From Two Monozygotic Patients and Validation in CRC Patient and Healthy Cohorts. Frontiers in Cellular and Infection Microbiology, 2021, 11, pp.749750. ⟨10.3389/fcimb.2021.749750⟩. ⟨hal-04543208⟩
-
Lucas Guillo, Guillaume Savoye, Aurélien Amiot, Cyrielle Gilletta, Maria Nachury, et al.. Prevalence of and factors associated with extraintestinal manifestations and their remission in inflammatory bowel disease: the EXTRA prospective study from the GETAID. Clinical and translational gastroenterology, 2023, 14 (12), pp.e00607. ⟨10.14309/ctg.0000000000000607⟩. ⟨hal-04206330⟩
-
-
Florence Canouï-Poitrine, Astrid Lièvre, Florent Dayde, Daniel Lopez-Trabada-Ataz, Isabelle Baumgaertner, et al.. Inclusion of Older Patients with Cancer in Clinical Trials: The SAGE Prospective Multicenter Cohort Survey. Oncologist, 2019, 24 (12), pp.e1351-e1359. ⟨10.1634/theoncologist.2019-0166⟩. ⟨hal-04126614⟩